Benitec Biopharma (BNTC) Amortizatization of Intangibles (2019 - 2025)

Benitec Biopharma has reported Amortizatization of Intangibles over the past 7 years, most recently at $106000.0 for Q4 2025.

  • Quarterly results put Amortizatization of Intangibles at $106000.0 for Q4 2025, up 260.61% from a year ago — trailing twelve months through Dec 2025 was $541000.0 (up 316.15% YoY), and the annual figure for FY2025 was $330000.0, up 28.91%.
  • Amortizatization of Intangibles reached $106000.0 in Q4 2025 per BNTC's latest filing, up from $105000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $330000.0 in Q2 2025 and bottomed at -$66000.0 in Q4 2024.
  • Median Amortizatization of Intangibles over the past 5 years was $61000.0 (2022), compared with a mean of $71842.1.
  • The largest annual shift saw Amortizatization of Intangibles tumbled 204.76% in 2024 before it soared 407.69% in 2025.
  • Over 5 years, Amortizatization of Intangibles stood at $58000.0 in 2021, then grew by 5.17% to $61000.0 in 2022, then rose by 3.28% to $63000.0 in 2023, then crashed by 204.76% to -$66000.0 in 2024, then skyrocketed by 260.61% to $106000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for BNTC at $106000.0 in Q4 2025, $105000.0 in Q3 2025, and $330000.0 in Q2 2025.